1Hunsicker LG. The consequences and costs of chronic kidney disease before ESRD[J]. J Am Soc Nephrol, 2004,15 (5) : 1363- 1364.
2Xue JL, Ma JZ, Louis TA, et al. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010[J]. J Am Soc Nephrol,2001,12(12) :2753-2758.
4Hogg RJ, Furth S, Lemley KV, et al. National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification [ J ]. Pediatrics,2003,1]1(6 Pt 1):1416-1421.
6Agrawal V, Ghosh AN, Barnes MA, et al. Awareness and knowledge of clinical practice guidelines for CKD among internal medicine residents: a national online survey[J]. Am J Kidney Dis,2008,52(6) ;1061- 1069.
8Snyder J J, Collins AJ. KDOQI hypertension, dyslipidemia, and diabetes care guidelines and current care patterns in the United States CKD population: National Health and Nutrition Examination Survey 1999 - 2004 [J]. Am J Nephrol, 2009,30 (1) :44-54.
3Xue JL,Ma JZ,Louis TA,et al.Forecast of the number of patients with end-stage renal disease in the United States to the year 2010.J Am Soc Nephrol,2001,12:2753-2758.
4Coresh J,Astor BC,Green T,et al.Prevalence of Chronic Kidney Disease and Decreased Kidney Function in the Adult US Population:Third National Health and Nutrition Examination Survey.Am J Kidney Dis,2003,41:1-12.
5Chobanian AV,Bakris GL,Black HR,et al.The Seventh Report of the Joint National Committee on prevention,detection,evaluation and treatment of high blood pressure.JAMA,2003,21:2560-2572.
6Anonymous.KDOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification.Kidney Disease Outcome Quality Initiative.Am J Kidney Dis,2002,39 Suppl 2:S1-S246.
7Chadban SJ,Briganti EM,Kerr PG,et al.Prevalence of kidney damage in Australian adults:the AusDiab kidney study.J Am Soc Nephrol,2003,14:S131-S138.
8Garg AX,Kiberd BA,Clark WF,et al.Albuminuria and renal insufficiency prevalence guides population screening:results form the NHANESⅢ.Kidney Int,2002,61:2165-2175.
9Ramirez SP,Mcclellan W,Port FK,et al.Risk factors for proteinuria in a large,multiracial,southeast Asian population.J Am Soc Nephrol,2002,13:1907-1917.
10Levey AS,Eckardt KU,Tsukamoto Y,et al.Definition and classification of chronic kidney disease:a position statement from Kidney Disease:Improving Global Outcomes (KDIGO).Kidney Int,2005,67:2089-2100.
4K./DOQI. Clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification[ J ]. AmJ Kidney Dis,2002,39( Suppl 1 ) :261-266.
5COCKCROFI" D W, GAULT M H. Prediction of creatinine clearance from serum ereatinine [ J ]. Nephron, 1976, 16 (1) :31-41.
6BOND C A, RAEHL C L, FRANKE T. Clinical pharmacy services, hospital pharmacy staffing, and medication errors in the United States hospitals [ J ]. Pharmacotherapy,2002, 22(1) :134-147.
7IRA S N, MARY R, PAUL H, et al. Reducing excessive medication administration in hospitalized adults with renal dysfunction [J]. Am J Med Qual,2005,20( 1 ) :64-69.
